United Therapeutics said the deal expands “existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D bioprinting, and ...

United Therapeutics aims to expand its portfolio of organ manufacturing platforms with the $91 million purchase of xenotransplant developer Miromatrix Medical. The deal shakes out to a price of $3 ...

United Therapeutics Organ Manufacturing Group Manchester, N.H. BEST PROJECT ... United Therapeutics had occupied 1.5 floors in the structure built in 1897 and, with this project, ...

The acquisition of Miromatrix will expand United Therapeutics’ existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D ...

United Therapeutics’ organ manufacturing efforts consist of seven investigational programs: xenoheart, xenokidney, xenothymokidney, regenerative lungs, 3D-printed lungs, 3D-printed livers, and ...

United Therapeutics announced in a company press release that it has agreed to terms to acquire Miromatrix Medical. Reportedly, the acquisition is expected to expand United Therapeutics’ existing ...

United Therapeutics in downtown Silver Spring has received FDA regulatory approval to begin clinical ... UT has gained global recognition for its groundbreaking work in organ manufacturing, ...

United Therapeutics’ UTHR fourth-quarter 2024 earnings of $6.19 per share beat the Zacks Consensus Estimate of $6.10. Earnings rose 42% year over year on the back of higher product sales. See ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., July 31, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the ...

United Therapeutics’ organ manufacturing efforts consist of seven investigational programs: xenoheart, xenokidney, xenothymokidney, regenerative lungs, 3D-printed lungs, 3D-printed livers, and ...

The acquisition of Miromatrix will expand United Therapeutics’ existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D ...